Publication | Open Access
Equol is more active than soy isoflavone itself to compete for binding to thromboxane A2 receptor in human platelets
48
Citations
25
References
2008
Year
InflammationThrombosisThrombopoiesisHuman PlateletsBiochemistryBlood PlateletMedicineHematologyHemostasisA2 ReceptorVascular BiologyPharmacotherapySoy IsoflavonePlatelet AntagonistPharmacologyAnticoagulantAtherosclerosis
| Year | Citations | |
|---|---|---|
Page 1
Page 1